Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
The Daily Galaxy on MSN
Scientists are testing a cellular reset that could push aging human cells back toward youth
Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
Beyond headlines and promises of eternal youth, advances in transplants, epigenetic clocks, and cellular reprogramming are redefining aging to help people live longer — and, above all, healthier. Some ...
It is well known that students who prepare in advance perform better on exams. Now, it appears that the skin can do the same. Rather than scrambling to repair itself only after injury occurs, a Korean ...
Billions of dollars are pouring into longevity startups as a growing body of research shows that aging might not be as inevitable as we assumed. Now, a startup claims to have reached a major milestone ...
A novel gene therapy that leads to cellular rejuvenation could restore vision after non-arteritic anterior ischemic optic neuropathy (NAION) and glaucoma. The technique is based on a reprogramming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results